Reuters logo
BRIEF-Oxford Biomedica and Sanofi amend Ocular licence terms
February 17, 2014 / 7:20 AM / 4 years ago

BRIEF-Oxford Biomedica and Sanofi amend Ocular licence terms

Feb 17 (Reuters) - Oxford BioMedica PLC : * And sanofi amend terms for ocular licence * Sanofi granted global rights across all ocular disease indications for

stargen and ushstat * Will regain the worldwide rights to encorstat, a treatment for corneal graft

rejection * Source text

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below